Globus Medical Quick Ratio 2010-2022 | GMED

Historical quick ratio values for Globus Medical (GMED) over the last 10 years.
Globus Medical Quick Ratio Historical Data
Date Current Assets - Inventory Current Liabilities Quick Ratio
2022-09-30 $0.64B $0.15B 4.39
2022-06-30 $0.63B $0.15B 4.28
2022-03-31 $0.66B $0.14B 4.68
2021-12-31 $0.63B $0.14B 4.48
2021-09-30 $0.75B $0.12B 6.09
2021-06-30 $0.66B $0.13B 5.08
2021-03-31 $0.58B $0.12B 4.71
2020-12-31 $0.59B $0.12B 4.91
2020-09-30 $0.58B $0.10B 5.80
2020-06-30 $0.47B $0.11B 4.45
2020-03-31 $0.43B $0.10B 4.42
2019-12-31 $0.49B $0.11B 4.41
2019-09-30 $0.45B $0.10B 4.74
2019-06-30 $0.41B $0.08B 4.88
2019-03-31 $0.47B $0.08B 5.97
2018-12-31 $0.50B $0.10B 5.20
2018-09-30 $0.52B $0.08B 6.39
2018-06-30 $0.52B $0.08B 6.46
2018-03-31 $0.51B $0.08B 6.15
2017-12-31 $0.51B $0.09B 5.50
2017-09-30 $0.45B $0.08B 6.03
2017-06-30 $0.42B $0.07B 6.14
2017-03-31 $0.43B $0.08B 5.68
2016-12-31 $0.40B $0.08B 5.02
2016-09-30 $0.36B $0.07B 5.51
2016-06-30 $0.43B $0.07B 6.13
2016-03-31 $0.41B $0.07B 5.67
2015-12-31 $0.44B $0.08B 5.32
2015-09-30 $0.40B $0.09B 4.24
2015-06-30 $0.35B $0.09B 3.86
2015-03-31 $0.36B $0.09B 3.82
2014-12-31 $0.38B $0.09B 4.24
2014-09-30 $0.41B $0.07B 5.60
2014-06-30 $0.39B $0.07B 5.92
2014-03-31 $0.39B $0.07B 5.36
2013-12-31 $0.35B $0.07B 5.10
2013-09-30 $0.31B $0.06B 5.36
2013-06-30 $0.27B $0.06B 4.71
2013-03-31 $0.26B $0.05B 5.67
2012-12-31 $0.30B $0.04B 7.54
2012-09-30 $0.28B $0.03B 8.11
2012-06-30 $0.24B $0.03B 8.29
2012-03-31 $0.23B $0.04B 6.47
2011-12-31 $0.21B $0.03B 7.22
2011-09-30 $0.00B 0.00
2011-06-30 $0.00B 0.00
2011-03-31 $0.00B 0.00
2010-12-31 $0.18B $0.03B 5.61
2009-12-31 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $7.103B $0.958B
Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its sales operations distributed across counties world wide. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and unique surgical instruments, used in an expansive range of spinal, orthopedic and neurosurgical procedures. The spine products address the vast majority of conditions affecting the spine including degenerative conditions, deformity, tumors and trauma. Enabling Technologies are designed to enhance a surgeon's capabilities and streamline the complicated surgical procedures to be safer, less invasive, accurate and more reproducible to improve patient care and reduce radiation exposure for both patient and caregiver. The technology contains imaging, navigation and robotic assisted surgery solutions. It acquired all assets of StelKast, Inc. and Finnish engineering company Synoste Oy.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $214.645B 22.45
Edwards Lifesciences (EW) United States $46.932B 32.30
Alcon (ALC) Switzerland $33.321B 28.69
STERIS (STE) Ireland $18.019B 22.42
Teleflex (TFX) United States $10.587B 17.18
Fresenius Medical Care AG KGaA (FMS) Germany $8.996B 9.03
Penumbra (PEN) United States $7.452B 1783.82
Integer Holdings (ITGR) United States $2.367B 19.00
Glaukos (GKOS) United States $2.263B 0.00
Nevro (NVRO) United States $1.556B 0.00
Paragon 28 (FNA) United States $1.534B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.246B 17.74
Artivion (AORT) United States $0.520B 0.00